Zelira in the news
For media related enquiries please contact Damien Carbon at Profile Media
Ph: +61 (0) 412 332 122 E: email@example.com
Zelira Therapeutics’ insomnia treatment gets TGA tick
Shares in Perth-based Zelira Therapeutics have surged after the medicinal cannabis company announced its insomnia treatment can now be prescribed in Australia.
The company’s stock was up 11.7 per cent to 6.7¢ at 12.50pm